Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment Following First-line Therapy Met Primary Endpoint
Globe Newswire12-04-2023, 10:47
Baidu Responds to Recent Media Reports on Ernie Bot 15-01-2024, 21:44